Praxis Precision Medicines, Inc. (PRAX) has a consensus analyst rating of Buy, based on 16 analysts covering the stock. Of those, 12 recommend buying, 3 recommend holding, and 1 recommend selling.
The analyst consensus price target for PRAX is $510.40, representing a +48.5% upside from the current price of $343.6. Price targets range from a low of $83.00 to a high of $843.00.
